Acute Pancreatitis: Clinical Trials

13 trials for Acute Pancreatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 1 recruiting, 1 terminated. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Completed 7, Unknown 4, Recruiting 1, Terminated 1

Follow Acute Pancreatitis: new trials by email Literature Review of Acute Pancreatitis trials Research Report on Acute Pancreatitis

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
Indomethacin SR, Placebos - Acute Pancreatitis, Complication
Phase 4RecruitingPeking Union Medical College Hospital15042024-12-012025-06-15
Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation
Lactated Ringer Solution, Normal saline - Acute Pancreatitis
Phase 4CompletedEnrique de-Madaria8122023-06-192026-08-18
Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis
insulin, standard treatment - Hypertriglyceridemia, Acute Pancreatitis
Phase 4UnknownUniversity Medical Centre Ljubljana302022-11-012022-11-01
Balanced Crystalloid Solutions for Acute Pancreatitis
Balanced crystalloid solution, Normal saline - Acute Pancreatitis
Phase 4UnknownUniversity Hospital Rijeka2762020-05-012020-12-30
Ketorolac in Acute Pancreatitis
Ketorolac - Acute Pancreatitis
Phase 4UnknownUniversity of Cincinnati602020-02-242020-12-08
Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.
Insulin, plasmapheresis - Acute Pancreatitis, Hypertriglyceridemia
Phase 4UnknownFirst Affiliated Hospital of Wenzhou Medical University2002018-06-062018-06-06
Treatment of Acute Pancreatitis With Ketorolac
Ketorolac - Acute Pancreatitis
Phase 4TerminatedIlam University of Medical Sciences562016-09-012019-05-15
Imipenem Prophylaxis in Patients With Acute Pancreatitis
Imipenem, Placebo - Acute Pancreatitis
Phase 4CompletedUniversity Hospital Rijeka982014-10-012017-06-20
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
Rectal indomethacin 100mg one time before or after ERCP - Acute Pancreatitis
Phase 4CompletedUniversity of Alberta5342014-04-012017-10-25
The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis
early enteral nutrition, Delayed enteral nutrition - Acute Pancreatitis, Intra-abdominal Hypertension
Phase 4CompletedNanjing University School of Medicine602010-09-012012-11-16
Enteral Nutrition in Acute Pancreatitis
Enteral nutrition - Acute Pancreatitis
Phase 4CompletedUniversity Hospital Rijeka2142007-05-012015-04-03
Activated Protein C in Severe Acute Pancreatitis
Activated protein C - Acute Pancreatitis
Phase 4CompletedHelsinki University Central Hospital322003-06-012010-10-14
Nutritional and Metabolic Evaluation of a Tube Feeding Immune Enhancing Diet in ICU Patients
Crucial (enteral tube feeding) - Neurological Diseases, Pneumopathy
Phase 4CompletedSociété des Produits Nestlé (SPN)222002-12-012013-11-19

Narrower conditions

Pancreatitis (13)  ·  Hypertriglyceridemia (2)  ·  Fasting (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Intra-Abdominal Hypertension (1)  ·  Lung Diseases (1)  ·  Multiple Organ Failure (1)  ·  Pancreatitis, Acute Necrotizing (1)

Broader conditions

Digestive System Diseases (13)  ·  Pancreatic Diseases (13)  ·  Dyslipidemias (2)  ·  Hyperlipidemias (2)  ·  Lipid Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Cardiovascular Diseases (1)  ·  Compartment Syndromes (1)  ·  Feeding Behavior (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)

Interventions

Enteral Nutrition (2)  ·  Insulin (2)  ·  Ketorolac (2)  ·  Saline Solution (2)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Imipenem (1)  ·  Indomethacin (1)  ·  Ketorolac Tromethamine (1)  ·  Plasmalyte A (1)  ·  Plasmapheresis (1)  ·  Protein C (1)  ·  Ringer's Lactate (1)  ·  Sodium Chloride (1)  ·  salicylhydroxamic acid (1)

Sponsors

University Hospital Rijeka (3)  ·  Enrique de-Madaria (1)  ·  First Affiliated Hospital of Wenzhou Medical University (1)  ·  Helsinki University Central Hospital (1)  ·  Ilam University of Medical Sciences (1)  ·  Nanjing University School of Medicine (1)  ·  Peking Union Medical College Hospital (1)  ·  Société des Produits Nestlé (SPN) (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Alberta (1)  ·  University of Cincinnati (1)

Countries

China (2)  ·  Croatia (2)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Iran (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Anthony J Gentene, PharmD (1)  ·  Baofeng Zhu, MD (1)  ·  Daoyuan Jing, MD (1)  ·  Davor Stimac, MD, PhD (1)  ·  Dong Wu, M.D. (1)  ·  Hong Liu, MD (1)  ·  Jianzhong Yang, MD (1)  ·  Mei Liu, M.D. (1)  ·  Meng-Tao Zhou, M.D. (1)  ·  Ming Sun, MD (1)  ·  Na Wu, M.D. (1)  ·  Ruifeng Wang, MD (1)

Results publications

PMID 12806612, PMID 17355281, PMID 17883296, PMID 20663207, PMID 22494121, PMID 23431120, PMID 23674254, PMID 25872171, PMID 27107634, PMID 31404018